MedTrace Logo

Controlled Study of the Effect of Xenaderm® Ointment Vehicle Versus White Petrolatum on Healing

NCT00713349 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2013-12-06

Study results available
· View outcomes & findings →

Summary

The objective of the study is to compare the healing of wounds induced by cryo-injury when treated with white petrolatum versus an ointment vehicle.

Conditions

  • Wounds

Interventions

DRUG

Xenaderm Vehicle

Ointment to be applied three times a day on cryo-surgery wound for 21 days.

OTHER

Placebo comparator

Ointment to be applied three times a day on cryo-surgery wound for 21 days.

Sponsors & Collaborators

  • Healthpoint

    lead INDUSTRY

Principal Investigators

  • Herbert R Slade, MD · Healthpoint

  • D. Innes Cargill, PhD · Healthpoint

  • Steven R Feldman, MD, PhD · Wake Forest

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2008-08-31
Completion
2008-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00713349 on ClinicalTrials.gov